ENTITY

Reprocell Inc (4978 JP)

Analysis

Health Care • Japan

ReproCell Incorporated develops iPS (Induced Pluripotent Stem Cell) business and clinical examination for organ transplantation based on human iPS and ES (Embryonic Stem Cell) technology.

Refresh

No presentations found

We’ll display presentations we find for Reprocell Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00